Third JCA-AACR Precision Cancer Medicine International Conference: New Frontiers in Precision Cancer Medicine through Innovative Modalities
June 28-30, 2025
Kyoto Tokyu Hotel
Kyoto, Japan
EXTENDED Abstract Submission Deadline: Wednesday, May 14, 12 p.m. JST (CLOSED)
EXTENDED Registration (On-site) Deadline: Friday, June 27, 2025, 5 p.m. JST
Registration Deadline for Live Online Viewing: Thursday, June 19, 2025, 5 p.m. JST
CONFERENCE COCHAIRS
Motohiro Kato, University of Tokyo, Tokyo, Japan
Victor E. Velculescu, Johns Hopkins University, Baltimore, Maryland, USA
Organizing Committee:
Philippe L. Bedard, University Health Network, Toronto, Ontario, Canada
Francesca deMichelis, University of Trento, Trento, Italy
Peter K. Sorger, Harvard University, Boston, Massachusetts, USA
Marcel R.M. van den Brink, City of Hope, Duarte, California, USA
Toshihiko Doi, National Cancer Center Hospital East, Japan
Takeshi Kohno, National Cancer Center, Tokyo, Japan
Hiroyoshi Nishikawa, Kyoto University, Kyoto, Japan
Emi Nishimura, University of Tokyo, Tokyo, Japan
Mamiko Sakata, Tsukuba University, Tsukuba, Japan
The JCA-AACR Precision Cancer Medicine International Conference is held every two to three years in Japan. This international collaboration will bring together the greatest minds from the United States, Japan, and around the world to share the latest and most exciting developments in precision cancer medicine. Led by conference cochairs Victor E. Velculescu and Motohiro Kato, the program will address timely topics such as advances in genome data science, hematologic malignancies, clonal hematopoiesis, pediatric cancer, immunotherapy, and cancer progression and treatment.